GANFORT 0.3/5 bimatoprost 0.3 mg/mL & timolol (as maleate) 5.0 mg/mL eye drops bottle Australia - English - Department of Health (Therapeutic Goods Administration)

ganfort 0.3/5 bimatoprost 0.3 mg/ml & timolol (as maleate) 5.0 mg/ml eye drops bottle

abbvie pty ltd - timolol maleate, quantity: 6.8 mg/ml (equivalent: timolol, qty 5 mg/ml); bimatoprost, quantity: 0.3 mg/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate heptahydrate; benzalkonium chloride; sodium hydroxide; purified water; citric acid monohydrate; hydrochloric acid; sodium chloride - ganfort eye drops are indicated for the reduction of intraocular pressure (iop) in patients with chronic open-angle glaucoma or ocular hypertension who are insufficiently responsive to monotherapy.

GANFORT PF 0.3/5 bimatoprost 0.3 mg/mL and timolol (as maleate) 5.0 mg/mL eye drops Australia - English - Department of Health (Therapeutic Goods Administration)

ganfort pf 0.3/5 bimatoprost 0.3 mg/ml and timolol (as maleate) 5.0 mg/ml eye drops

abbvie pty ltd - timolol maleate, quantity: 6.8 mg/ml (equivalent: timolol, qty 5 mg/ml); bimatoprost, quantity: 300 microgram/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate heptahydrate; hydrochloric acid; citric acid monohydrate; purified water; sodium chloride; sodium hydroxide - ganfort pf 0.3/5 eye drops are indicated for the reduction of intraocular pressure (iop) in patients with chronic open-angle glaucoma or ocular hypertension who are insufficiently responsive to monotherapy.

GANFORT PF EYE DROPS (Bimatoprost 0.3mgml Timolol 5.0mgml) Singapore - English - HSA (Health Sciences Authority)

ganfort pf eye drops (bimatoprost 0.3mgml timolol 5.0mgml)

abbvie pte. ltd. - bimatoprost; timolol maleate 6.8 mg/ml eqv timolol - solution, sterile - bimatoprost 0.3 mg/ml; timolol maleate 6.8 mg/ml eqv timolol 5 mg/ml

Eyzeetan 0.3 mg/ml + 5 mg/ml eye drops, solution Ireland - English - HPRA (Health Products Regulatory Authority)

eyzeetan 0.3 mg/ml + 5 mg/ml eye drops, solution

aspire pharma limited - bimatoprost; timolol maleate - eye drops, solution - 0.3/5 milligram(s)/millilitre - timolol, combinations

Eyzeetan 0.3 mg/ml + 5 mg/ml eye drops, solution Ireland - English - HPRA (Health Products Regulatory Authority)

eyzeetan 0.3 mg/ml + 5 mg/ml eye drops, solution

european regulatory affairs t/a ivowen - bimatoprost; timolol maleate - eye drops, solution - 0.3/5 milligram(s)/millilitre - timolol, combinations

Eyzeetan 0.3 mg/ml + 5 mg/ml eye drops, solution Ireland - English - HPRA (Health Products Regulatory Authority)

eyzeetan 0.3 mg/ml + 5 mg/ml eye drops, solution

morningside healthcare (malta) limited - bimatoprost; timolol maleate - eye drops, solution - timolol, combinations

Bitifrin 0.3 mg/ml + 5 mg/ml eye drops, solution Ireland - English - HPRA (Health Products Regulatory Authority)

bitifrin 0.3 mg/ml + 5 mg/ml eye drops, solution

farmaprojects s.a. - bimatoprost; timolol maleate - eye drops, solution - timolol, combinations

Ganzed 0,3 mg/ml - 5 mg/ml eye drops sol. dropper cont. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ganzed 0,3 mg/ml - 5 mg/ml eye drops sol. dropper cont.

horus pharma - timolol maleate 6,83 mg/ml - eq. timolol 5 mg/ml; bimatoprost 0,3 mg/ml - eye drops, solution - 0,3 mg/ml - 5 mg/ml - bimatoprost 0.3 mg/ml; timolol maleate 6.83 mg/ml - timolol, combinations

Vizimaco 0.3 mg/ml - 5 mg/ml eye drops sol. multidos. cont. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vizimaco 0.3 mg/ml - 5 mg/ml eye drops sol. multidos. cont.

bausch + lomb ireland - timolol maleate 6,83 mg/ml - eq. timolol 5 mg/ml; bimatoprost 0,3 mg/ml - eye drops, solution - 0,3 mg/ml + 5 mg/ml - bimatoprost 0.3 mg/ml; timolol maleate 6.83 mg/ml - timolol, combinations

GANFORT Israel - English - Ministry of Health

ganfort

abbvie biopharmaceuticals ltd, israel - bimatoprost; timolol as maleate - eye drops, solution - bimatoprost 0.3 mg/ml; timolol as maleate 5 mg/ml - timolol - timolol - reduction of intraocular pressure in patients with open- angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.